Search clinical trials for: Clopenthixol

Total 19 results

Birte Glenthoj
Rigshospitalet, Denmark; University of Copenhagen; Hvidovre University Hospital; The Novo Nordic Foundation and other collaborators

Completed

Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia

Schizophrenia

Denmark
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Infusion Laboratory: Protocol 5 (Flupenthixol) - 14

Cocaine-Related Disorders

United States
Peking University Third Hospital

Completed

Flupentixol and Melitracen Tablets in the Treatment of Emotional Disorder

Emotional Disorder | Neurologic Disorder

China
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Cocaine Abuse and ADHD - 10

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Friends Research Institute, Inc.

Completed

Flupenthixol Decanoate in Methamphetamine Smoking - 1

Substance-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9

Substance-Related Disorders | Cocaine-Related Disorders

United States
H. Lundbeck A/S

Completed

Bioequivalence Study to Compare Two Formulations of Deanxit®

Healthy

China
H. Lundbeck A/S

Completed

Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®)

Healthy Men and Women

United Kingdom
Taichung Veterans General Hospital

Completed

Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients

Central Nervous System Diseases | Metabolic Syndrome | Schizophrenia; Psychosis | Antipsychotic Agents | Olanzapine | Flupentixol | Clinical Therapy | Quetiapine

Taiwan
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Antipsychotics and Risk of Hyperglycemic Emergencies

Psychotic Disorders | Diabetes Mellitus, Type 2 | Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

Canada
Mahidol University

Completed

Treatment in Patients With Globus: Psychoeducation, Anxiolytics or Proton Pump Inhibitors

Globus

Thailand
Technical University of Munich

Completed

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

Schizophrenia | Schizoaffective Disorders | Schizophrenia and Disorders With Psychotic Features

Germany
RenJi Hospital

Recruiting

The Role of Neuromodulators in Refractory Functional Dyspepsia

Dyspepsia | Functional Gastrointestinal Disorders | Antidepressant Drug Adverse Reaction | Antidepressant Discontinuation Syndrome

China
H. Lundbeck A/S

Completed

Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations

Bioequivalence Study in Healthy Subjects

Russian Federation
University of Bremen
German Federal Ministry of Education and Research

Completed

Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia (NeSSy)

Schizophrenia

Germany
RenJi Hospital

Completed

Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia

Depression | Dyspepsia | Compliance

China
Fundación Pública Andaluza Progreso y Salud
Instituto de Salud Carlos III

Unknown

Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis (NONSTOP)

Psychosis Nos/Other

Spain
Hannover Medical School

Terminated

Pharmacovigilance in Gerontopsychiatric Patients (GAP)

Depression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic Disorders

Germany

Search clinical trials for: Clopenthixol

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations